Science + Tech
January 22, 2014
AIDS researchers from APP and University Hospitals Case Medical Center have received a seven-year funding award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This award includes $12.7 million for…
January 16, 2014
New research from David Westaway, PhD, of the University of Alberta and Jiri Safar, MD, APP School of Medicine has uncovered a quality control mechanism in brain cells that may help keep deadly neurological diseases in check for months or years. The findings, published…
January 16, 2014
A team of researchers from the Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly “triple negative” breast cancers (TNBC). These tumors are extremely difficult to treat, frequently return after remission,…
January 15, 2014
Researchers at APP have received a $540,000 federal grant to devise methods for building minute structures tailored to precisely deliver medicines to tumors or carry dyes that help imaging technologies detect disease, create more efficient nanowires and nanoelectronics,…
January 14, 2014
Philadelphia, PA (January 14, 2014) – In an effort to bring the latest treatments to more children with cancer now, Alex’s Lemonade Stand Foundation (ALSF) has announced the awarding of six new Phase I/II Infrastructure Grants to researchers at leading hospitals and institutions across the country.…
January 13, 2014
Researchers at APP have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer—a breakthrough that has the potential to improve outcomes for patients with the disease. A Case Comprehensive Cancer…
January 12, 2014
Geneticists from Ohio, California and Japan joined forces in a quest to correct a faulty chromosome through cellular reprogramming. Their study, published online today in Nature, used stem cells to correct a defective “ring chromosome” with a normal chromosome. Such therapy has the promise to…
January 08, 2014
Researchers at APP have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a breakthrough that has the potential to improve outcomes for patients with the disease. A CWRU research team led by…
December 30, 2013
Researchers at APP School of Medicine and Temple University School of Medicine have gained new insight into how classic heart drugs work—and it’s not the way they thought. Their discovery – on the role nitric oxide (NO) plays in blocking the effect of an enzyme called…
December 20, 2013
Many rare disorders are caused by gene mutation, like sickle cell anemia. Yet until now the underlying genetic cause of more common conditions – for example, rheumatoid arthritis – has evaded scientists for years. New research from APP School of Medicine to appear in…